arrow
T

Tristan Barrett

University of Toronto
H指数:54
被引数:9,393

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Current status and future directions of AI in prostate cancer detection on MRI: a special report from the ESUR prostate MRI working group authors

人工智能在前列腺癌MRI检测中的现状与未来方向:ESUR前列腺MRI工作组报告作者

2026-09-180
OAAI
The Imperial Prostate 9-Approaches To Long-term Active Surveillance: Regular MRI scans versus standard of care (IP9-ATLAS) randomised controlled trial

帝国前列腺9种方法长期主动监测:常规MRI扫描与标准护理的随机对照试验(IP9-ATLAS)

2026-06-010
OAAI
Multicentre validation of the PRECISE scoring system for prostate MRI during active surveillance

多中心验证用于前列腺MRI主动监测的PRECISE评分系统

2026-05-040
OAAI
PROSTATE IMAGING STANDARDS FOR SCREENING MAGNETIC RESONANCE IMAGING (PRISM): INTERNATIONAL CONSENSUS RECOMMENDATIONS

前列腺影像标准用于筛查磁共振成像(PRISM):国际共识建议

2026-05-010
PRE
PRECISE Version 2: Essential Tips for Prostate Cancer Monitoring Using MRI

PRECISE Version 2:使用MRI进行前列腺癌监测的关键要点

2026-05-010
PRE
Systematic effects of patient factors and scanner/protocol factors on a Restriction Spectrum Imaging (RSI) quantitative MRI biomarker for prostate cancer

患者因素和扫描仪/协议因素对前列腺癌Restriction Spectrum Imaging (RSI)定量MRI生物标志物的系统性影响

2026-04-160
OAAI
Long-term outcomes of cribriform-positive and cribriform-negative prostate cancer treated with radical prostatectomy in the ProtecT trial

多科协作试验中, cribriform阳性与cribriform阴性前列腺癌手术治疗的长远结局

2026-03-011
OAAI
AI decision support for increasing prostate biopsy efficiency: a retrospective multicentre, multiscanner study

AI决策支持以提高前列腺活检效率:一项回顾性多中心、多扫描仪研究

2026-02-200
OAAI
Deep Learning Artificial Intelligence and Restriction Spectrum Imaging for Patient-level Detection of Clinically Significant Prostate Cancer on Biparametric Magnetic Resonance Imaging
2026-02-060
OAAI
Diagnostic accuracy of a 'stage-gated' approach for reporting prostate screening MRI: Is less more?

一种“阶段门控”方法在前列腺筛查MRI报告中的诊断准确性:少即是多吗?

2026-02-011
PRE
The ‘Comparison of diagnostic accuracy of Luminal Index and standard of care MRI for Accelerated deTEction of prostate cancer’ (CLIMATE) trial protocol
2026-01-250
PRE
Evaluating the metabolic effects of neoadjuvant treatment in clear cell renal cell carcinoma using hyperpolarized [1-13 C]pyruvate MRI

评估透明细胞肾细胞癌新辅助治疗的代谢效应:采用高极化[1-13 C]丙酮酸MRI

2025-12-010
OAAI